RxSight, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- RxSight, Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-09-30 was $46.00K.
- RxSight, Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-06-30 was $125.00K, a 97.56% decline year-over-year.
- RxSight, Inc. stock issued during period, value, stock options exercised for the quarter ending 2020-06-30 was $5.13M.
- RxSight, Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $347.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2021-12-31 | $347.00K 10-K · filed 2022-03-08 | |
| 2021-09-30 | $46.00K 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $125.00K 10-Q · filed 2022-11-07 | |
| 2020-06-30 | $5.13M 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |